Page 2 - Stock Analysis
Why are analysts optimistic on PB Fintech despite regulatory concerns?
PB Fintech shares fell over 5% despite strong Q4FY26 results with robust premium growth and margin expansion. Analysts remain positive on Policybazaar and Paisabazaar's long-term growth potential.
 "Why are analysts optimistic on PB Fintech despite regulatory concerns?")
Brokerages bullish on M&M on SUV growth, product pipeline; flag margin risk
M&M Q4 results analysis: Brokerages stay bullish on M&M amid strong SUV growth and earnings outlook. They see up to 43 per cent upside in M&M share price despite margin pressure, tractor sales' risks
 "Brokerages bullish on M&M on SUV growth, product pipeline; flag margin risk")
Strong EV demand, diversified portfolio to sustain growth for Sona BLW
Strong EV demand and a robust order book power Q4 beat, but valuations and global slowdown concerns keep brokerages cautious
 "Strong EV demand, diversified portfolio to sustain growth for Sona BLW")
Ambuja Cements slips 3% on Q4 miss; brokerages cut estimates, target price
Ambuja Cements reported a consolidated net profit of ₹1,830 crore in the Q4FY26, up 78.5 per cent from ₹1,025 crore in the year-ago period
 "Ambuja Cements slips 3% on Q4 miss; brokerages cut estimates, target price")
Improving mix, volumes seen driving growth recovery for Max Healthcare
Brokerages remain positive on Max Healthcare despite recent weakness, expecting growth revival in FY27 led by expansion, better occupancy, improved mix and strong margins
 "Improving mix, volumes seen driving growth recovery for Max Healthcare")
Navin Fluorine posts healthy Q4; analysts stay positive on growth outlook
Navin Fluorine shares gained 7 per cent post Q4 results but pared gains later; analysts bullish on growth outlook
 "Navin Fluorine posts healthy Q4; analysts stay positive on growth outlook")
Local growth powers Maruti Suzuki India outlook despite margin pressure
Maruti Suzuki shares rose after a strong Q4 performance, with analysts positive on domestic demand outlook despite near-term pressure on margins from higher costs.
 "Local growth powers Maruti Suzuki India outlook despite margin pressure")
UltraTech Cement delivers a Q4 beat; cost pressures keep analysts wary
UltraTech Cement posts strong Q4FY26 results, but analysts stay cautious due to cost pressures, capacity expansion risks, and sector headwinds
 "UltraTech Cement delivers a Q4 beat; cost pressures keep analysts wary")
Lack of growth visibility at Organon could cap Sun Pharma's gains
Sun Pharma's Organon deal lifts stock, but growth concerns and high debt at the acquired firm may cap upside despite synergy potential
 "Lack of growth visibility at Organon could cap Sun Pharma's gains")
Reliance Industries stock likely to take a hit after muted Q4 show
Weak O2C performance drives analysts to cut target price, earnings estimates even as valuation helps retain 'buy' ratings
 "Reliance Industries stock likely to take a hit after muted Q4 show")
Cipla gains US FDA nod for Ventolin; analysts see $100 mn sales potential
Cipla has received the US FDA's approval for generic Ventolin inhaler. Analysts see $100-million sales potential from the drug, which could aid US business outlook
 "Cipla gains US FDA nod for Ventolin; analysts see $100 mn sales potential")
IKS Health shares jump 9% on TruBridge acquisition; deal seen EPS accretive
IKS Health shares surged 9.5 per cent after announcing a $557-million TruBridge acquisition. The deal, it said, will boost EPS outlook, add EHR SaaS, and unlock $575-million cross-sell potential
 "IKS Health shares jump 9% on TruBridge acquisition; deal seen EPS accretive")
InCred Equities initiates on Techno Electric with 'Buy', eyes 34% upside
Techno Electric & Engineering Company is a leading EPC player in India's power transmission and distribution sector with over 45 years of experience and a proven track record across major projects
 "InCred Equities initiates on Techno Electric with 'Buy', eyes 34% upside")
Axis Securities initiates on Jubilant Ingrevia with 'Buy', sees 21% upside
Jubilant is going through a strategic transformation from a commodity-heavy business to a specialised niche player, aiming to increase the share of speciality products across segments
 "Axis Securities initiates on Jubilant Ingrevia with 'Buy', sees 21% upside")
Elara initiates on Sagility with Buy; sees long growth runway, 26% upside
Elara Capital expects Sagility to report revenue and earnings CAGRs of 13.9 per cent and 20.0 per cent, respectively, in INR terms over FY26E-FY28E
 "The Batra Hedge Framework: A Smarter Way to Think About Investing")
Antique initiates on Flair Writing Industries with 'Buy', sees 60% upside
Antique has initiated coverage on Flair Writing Industries with a target price of ₹520, valuing the stock at 26x FY28 estimated earnings
Dixon Tech stock: MOFSL sees 30% upside, flags near-term margin pressure
Motilal Oswal sees 30% upside in Dixon Technologies share price despite near-term headwinds from weak smartphone demand and rising costs. The brokerage has reiterated 'Buy' with ₹14,700 target price
 "Dixon Tech stock: MOFSL sees 30% upside, flags near-term margin pressure")
Groww share price soars 43% thus far in April; BofA sees more upside
BofA sees scope for re-rating as Groww drives further margin expansion, and establishes a credible present in wealth management
 "Groww share price soars 43% thus far in April; BofA sees more upside")
Dabur faces growth headwinds as rural demand, costs cloud outlook
Weak monsoon fears, West Asia turmoil, and rising costs cloud outlook
 "Dabur faces growth headwinds as rural demand, costs cloud outlook")